Valuation (22%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -202.55 | 28.95 |
PEG Ratio (TTM) | -3.59 | 5.02 |
P/S Ratio (TTM) | 6.88 | 89.85 |
P/B Ratio (TTM) | 3.06 | 74.05 |
P/FCF Ratio (TTM) | 30.34 | 65.18 |
Price to 5YR AVG Earnings Ratio | N/A | 26.86 |
Price to 5YR AVG FCF Ratio | N/A | 50.98 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -1.05% | 4.62% |
ROE (TTM) | -1.52% | 8.81% |
Net Profit Margin (TTM) | -3.57% | -10.17% |
ROIC 5YR AVG | N/A | 17.25% |
Growth (35%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -16.11% | -1,275.55% | N/A |
Revenue | 3.92% | 103.91% | N/A |
Net Income | -15.92% | 17.57% | N/A |
Cash Flow | 492.41% | 12.12% | N/A |
Health (42%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 2.70 | 5.91 |
Quick Ratio (TTM) | 2.67 | 5.77 |
D/E Ratio (TTM) | 0.05 | 0.70 |
Interest Coverage (TTM) | -1.75 | 18.00 |
Piotroski F-Score | 5 | 6 |
Altman Z-Score | N/A | 6.37 |
LTL to 5YR AVG FCF | N/A | 2.48 |
Shares Outstanding Growth 5YR AVG | N/A | 13.17% |